3.34MMarket Cap-0.06P/E (TTM)
0.3255High0.3011Low250.44KVolume0.3140Open0.3112Pre Close78.45KTurnover2.31%Turnover RatioLossP/E (Static)10.83MShares2.100052wk High0.48P/B3.33MFloat Cap0.197052wk Low--Dividend TTM10.83MShs Float221.0000Historical High--Div YieldTTM7.84%Amplitude0.0026Historical Low0.3130Avg Price1Lot Size
SciSparc Stock Forum
Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea
Monday, 10th March at 7:27 am
Vancouver, Canada, March 10, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems,...
No comment yet